(Q52397402)
Statements
Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial) (English)
1 reference
U Goldbourt
1 reference
S Behar
1 reference
H Reicher-Reiss
1 reference
J Agmon
1 reference
E Kaplinsky
1 reference
E Graff
1 reference
Y Kishon
1 reference
A Caspi
1 reference
J Weisbort
1 reference
L Mandelzweig
1 reference
1 April 1993
1 reference
71
1 reference
11
1 reference
909-915
1 reference